Day: March 26, 2024

Probe Gold Files PEA Update Technical Report for the Novador Project, Quebec

Probe Gold Files PEA Update Technical Report for the Novador Project, Quebec

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) — PROBE GOLD INC. (TSX-V: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is pleased to announce the filing of the independent Preliminary Economic Assessment (“PEA”) technical report  which has been prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects, on its 100% owned Novador Project, located in Val-d’Or, Québec. The Novador PEA supports a robust mining plan that averages over 255,000 ounces per year of gold production, with over 281,000 ounces per year in the first five years of the 12.6-year mine life and boasts an impressive after-tax NPV of $910 million using a base-case gold price of US$1,750/oz. The technical report, entitled “Novador Project, NI 43-101 Technical Report & Preliminary Economic Assessment” (the “Novador...

Continue reading

<div>Petrus Resources Announces Year End 2023 Financial, Operating & Reserves Results</div>

Petrus Resources Announces Year End 2023 Financial, Operating & Reserves Results

CALGARY, Alberta, March 26, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three and twelve months ended December 31, 2023 and to provide 2023 year end reserves information as evaluated by Insite Petroleum Consultants Ltd. (“Insite”). The Company’s Management’s Discussion and Analysis (“MD&A”) and audited consolidated financial statements are available on SEDAR+ (the System for Electronic Document Analysis and Retrieval) at www.sedarplus.ca. An updated corporate presentation as well as the monthly activity update can be found on the Company’s website at www.petrusresources.com. Q4 2023 HIGHLIGHTS Dividends – The Company declared a regular monthly dividend of $0.01 per share,...

Continue reading

The AI revolution is here: Samsung brings Galaxy AI to more smartphones

The AI revolution is here: Samsung brings Galaxy AI to more smartphones

For a limited time, get a Galaxy S23 with Galaxy AI on us with a new line on Verizon myPlan¹ NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) — Verizon customers will soon be able to experience Samsung One UI 6.1 with Galaxy AI2 on additional Samsung smartphones beyond the Galaxy S24 series. This expansion includes popular models, such as the Galaxy S23 series, Galaxy S23 FE, Galaxy Z Fold5 and Galaxy Z Flip5. With this update, you can unlock a host of innovative features to enhance your life, work and mobile experience. Verizon Galaxy S23 Offer: Check everything Galaxy AI has to offer with this amazing deal. For a limited time, get a new Galaxy S23 on us when you purchase your new phone with a new line on myPlan – no trade-in required1. Whether you’re upgrading to the Galaxy S23 series, Galaxy S23 FE, Galaxy Z Fold5 and Galaxy Z Flip5,...

Continue reading

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of macular injury associated with progressive multiple sclerosis. Once issued, this patent is expected to expire no earlier than October 2039.  The allowed claims cover the use of MN-166 (ibudilast) for treating macular injury associated with progressive multiple sclerosis and for decreasing macular volume loss associated with progressive multiple sclerosis. The allowed claims specifically cover both primary progressive multiple sclerosis and secondary...

Continue reading

Orezone Reports 2023 Year-end and Q4 Results, and Provides 2024 Guidance

Orezone Reports 2023 Year-end and Q4 Results, and Provides 2024 Guidance

VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the fourth quarter and full-year ended December 31, 2023.   The Company will host a conference call and webcast on March 27, 2024 commencing at 8:00am PDT to discuss its 2023 results and 2024 guidance. Additional details are provided at the end of this press release. All dollar amounts are in USD unless otherwise stated and abbreviation “M” means million. Patrick Downey, President and CEO, commented “We had strong end to the year with the production of 33,916 gold ounces in the fourth quarter, allowing us to meet our full year production and cost guidance metrics. In its first full year of commercial production, the Bomboré mine was successful...

Continue reading

Movella Announces Nasdaq’s Planned Suspension of Trading of Securities

Movella Announces Nasdaq’s Planned Suspension of Trading of Securities

HENDERSON, Nev., March 26, 2024 (GLOBE NEWSWIRE) — Movella Holdings Inc. (NASDAQ: MVLA) (“Movella” or the “Company”), a leading full-stack provider of sensors, software, and analytics that enable the digitization of movement, announced today that it was notified by the Nasdaq Stock Market LLC (“Nasdaq”) of the timing of Nasdaq’s planned suspension of trading of the Company’s securities. As previously disclosed in its Current Report filed on Form 8-K with the Securities and Exchange Commission (the “SEC”) on March 20, 2024 (the “8-K”), the Company notified Nasdaq of the Company’s decision to voluntarily delist its shares of common stock, par value $0.00001 per share (the “Common Stock”) and its warrants exercisable for one share of Common Stock at an exercise price of $11.50 (the “Warrants” and together with the Common Stock, the...

Continue reading

Regenx Announces Rights Offering and Share Consolidation

Regenx Announces Rights Offering and Share Consolidation

EDMONTON, Alberta, March 26, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx“) (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announced that it will be offering rights (the “Rights Offering“) to holders of its common shares (“Common Shares“) of record at the close of business on April 2, 2024 (the “Record Date”). Pursuant to the Rights Offering, each holder of Common Shares (a “Shareholder”) will receive one (1) transferable right (each, a “Right”) for each Common Share held as of the Record Date. One (1) Right will entitle the holder thereof to subscribe for one Common Share upon payment of the subscription price of $0.0075 (3/4 of a cent) per Common Share until 5:00 p.m. (Toronto time) (the “Expiry Time”) on May 21, 2024. Assuming the exercise of all Rights,...

Continue reading

AMC Networks Inc. Announces Pricing of Upsized Private Offering of $875 Million of 10.25% Senior Secured Notes due 2029

AMC Networks Inc. Announces Pricing of Upsized Private Offering of $875 Million of 10.25% Senior Secured Notes due 2029

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) today announced that it has priced an offering of $875 million aggregate principal amount of 10.25% senior secured notes due 2029 (the “Notes”) in a private offering, which represents an increase of $175 million in aggregate principal amount of the Notes from the amount announced at the launch of the offering. The Notes will be unconditionally guaranteed, on a joint and several basis, by each of AMC Networks’ existing and future domestic subsidiaries, subject to certain exceptions, on a senior secured basis. AMC Networks expects to use the net proceeds from the offering of the Notes to fund its tender offer (the “Tender Offer”) to purchase for cash any and all of its outstanding approximately $775 million of 4.75% Senior...

Continue reading

<div>World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain</div>

World First Use of Lightpoint’s SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain

LONDON, March 27, 2024 (GLOBE NEWSWIRE) — Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first bladder cancer sentinel lymph node (SLN) procedure with SENSEI®, Telix’s miniature robotic-assisted gamma probe used to detect radiation in patients and guide surgery. The patient was operated on at Hospital del Mar in Barcelona, Spain. SENSEI® is smaller than an AA battery and designed specifically for robotic-assisted and minimally invasive surgery. The miniature size and proprietary features make the technology ideal for tight surgical spaces such as around the bladder. With broad application in radio-guided surgery across multiple procedures and major cancer types, SENSEI® is currently indicated for use during SLN biopsy in prostate,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.